Phase I Study of MLN8237 and Pazopanib in Patients With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Melanoma
Related studies linked through entity extraction aliases.
A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
CAVATAK in Patients With Stage IIIc or IV Malignant Melanoma to Extend Dosing to 48 Weeks (VLA-008 CALM Ext)
- Status
- COMPLETED
- Phase
- PHASE2
A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas
- Status
- COMPLETED
- Phase
- PHASE1
Multiple Antigen-Engineered DC Vaccine for Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
Assessing the Patient Experience in Cancer Care
- Status
- COMPLETED
- Phase
- N/A
An Open-Label Phase II Study of the Combination of GSK2118436 and GSK1120212 in Patients With Metastatic Melanoma Which is Refractory or Resistant to BRAF Inhibitor
- Status
- COMPLETED
- Phase
- PHASE2
Leflunomide+Vemurafenib in V600 Mutant Met. Melanoma
- Status
- TERMINATED
- Phase
- PHASE1
Neoadjuvant Combination Therapy With Ipilimumab and HighDose IFN-α2b for Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
A Phase 1/2 Randomized, Blinded, Placebo Controlled Study of Ipilimumab in Combination With Epacadostat or Placebo in Subjects With Unresectable or Metastatic Melanoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Systemic Therapy With Interferon, Interleukin-2 and BRAF Inhibitor
- Status
- COMPLETED
- Phase
- PHASE1
Dabrafenib Plus Trametinib vs Vemurafenib Alone in Unresectable or Metastatic BRAF V600E/K Cutaneous Melanoma
- Status
- COMPLETED
- Phase
- PHASE3
Doxycycline, Temozolomide and Ipilimumab in Melanoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Intensity-Modulated or Proton Radiation Therapy for Sinonasal Malignancy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Transfer of Genetically Engineered Lymphocytes in Melanoma Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Vemurafenib and White Blood Cell Therapy for Advanced Melanoma
- Status
- TERMINATED
- Phase
- PHASE1
A Multipeptide Vaccine Plus Toll-Like Receptor Agonists in Melanoma Patients
- Status
- COMPLETED
- Phase
- PHASE1
A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma
- Status
- COMPLETED
- Phase
- PHASE3
Study of Circulating Tumor Cells Before and After Treatment in Patients With Metastatic Melanoma
- Status
- COMPLETED
- Phase
- NA
Pilot Study Evaluating Sulforaphane in Atypical Nevi-Precursor Lesions
- Status
- COMPLETED
- Phase
- EARLY_PHASE1